-+ 0.00%
-+ 0.00%
-+ 0.00%

Summit Therapeutics' shares fell 29%; its lung cancer drug was rejected by the FDA.

Zhitongcaijing·11/16/2026 09:10:28
Listen to the news
Summit Therapeutics' shares fell 29%; its lung cancer drug was rejected by the FDA.